Chad Therapeutics Aktie - CTU

Professionelle Tools für Privatanleger.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it plans to withdraw its common stock from the American Stock Exchange...

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

Dormio Tech, a division of CHAD Therapeutics, Inc. (AMEX:CTU), announced today that it received 510(K) clearance from the FDA to...

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics, Inc. (AMEX:CTU) today announced that on July 23, 2008, it received a letter from the American Stock Exchange...

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics, Inc. (AMEX:CTU) today reported that its independent registered accountants, Rose, Snyder & Jacobs, had...

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has closed the sale of the assets related to its transfilling oxygen...

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics, Inc. (AMEX:CTU) announced that it has closed the sale of the assets related to CHAD's oxygen conserving...

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today announced operating results for the third quarter and first nine months of fiscal 2008...

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

Following a special meeting of shareholders held today, CHAD Therapeutics, Inc. (AMEX:CTU) announced that its shareholders have...

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has commenced mailing its definitive proxy statement to shareholders...

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008. First Quarter...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CTU - Frequently Asked Questions (FAQ)

What is the current Chad Therapeutics share price?

The current share price of Chad Therapeutics is US$ 0,00

What is the 1 year trading range for Chad Therapeutics share price?

Chad Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FLAGGlobal X S&P 500 US Market Leaders Top 50 ETF	US$ 24,69 (208,63%)	1,46k
BTTRBetter Choice Company Inc	US$ 2,025 (46,20%)	315,77k
CHROChannel Therapeutics Corporation	US$ 1,76 (40,24%)	39,58M
LLYXDefiance Daily Target 2X Long LLY ETF	US$ 19,57 (28,50%)	881,26k
DJTUT REX 2X Long DJT Daily Target ETF	US$ 19,17 (24,36%)	85,52k
FOXOFOXO Technologies Inc	US$ 0,0841 (-22,84%)	1,65M
NVOXDefiance Daily Target 2x Long Nvo ETF	US$ 4,82 (-15,69%)	282,82k
AZTRAzitra Inc	US$ 0,28 (-11,95%)	381,57k
PTNPalatin Technologies Inc New	US$ 0,217001 (-11,79%)	13,13M
TOPPToppoint Holdings Inc	US$ 1,08 (-11,48%)	6,36k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 9,20 (-1,50%)	233,66M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 7,7151 (-0,06%)	83,19M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 3,66 (0,14%)	78,84M
SPYSPDR S&P 500	US$ 526,41 (0,14%)	78,53M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3,57 (6,09%)	69,9M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Chad Therapeutics, (CTU)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

CTU Neueste Nachrichten

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CTU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Chad Therapeutics, (CTU) Börsenkurse

Chad Therapeutics, (CTU)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

CTU Neueste Nachrichten

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CTU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE